Henna Rautiainen

Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis

Henna Rautiainen, Päivi Kärkkäinen, A.-L. Karvonen et al. · Hepatology · 2005 · 224 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD

Pauliina Molander, Taina Sipponen, Helena Kemppainen et al. · Journal of Crohn s and Colitis · 2012 · 115 citations

Pharmacy, Immunology, Pharmacotherapy +17

Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?

Pauliina Molander, Martti Färkkilâ, Ari Ristimäki et al. · Journal of Crohn s and Colitis · 2014 · 94 citations

Veterinary Medicine, Immunology, Pharmacotherapy +15

Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy

Taina Sipponen, Johanna Haapamäki, Erkki Savilahti et al. · Scandinavian Journal of Gastroenterology · 2012 · 90 citations

Medicine, Pathology, Early Detection +16

Outcome After Discontinuation of TNFα-blocking Therapy in Patients with Inflammatory Bowel Disease in Deep Remission

Pauliina Molander, Martti Färkkilâ, Kimmo Salminen et al. · Inflammatory Bowel Diseases · 2014 · 75 citations · Full text

Pharmacy, Immunology, Gastrointestinal Pharmacotherapy +15